Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 675 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
How did PGNY's recent EPS compare to expectations?
The most recent EPS for Progyny Inc is $0.34, not beating expectations of $0.34.
How did Progyny Inc PGNY's revenue perform in the last quarter?
Progyny Inc revenue for the last quarter is $0.34
What is the revenue estimate for Progyny Inc?
According to 12 of Wall street analyst, the revenue estimate of Progyny Inc range from $369.6M to $329.77M
What's the earning quality score for Progyny Inc?
Progyny Inc has a earning quality score of B+/51.453598. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Progyny Inc report earnings?
Progyny Inc next earnings report is expected in 2026-11-04
What are Progyny Inc's expected earnings?
Progyny Inc expected earnings is $355.65M, according to wall-street analysts.
Did Progyny Inc beat earnings expectations?
Progyny Inc recent earnings of $350.51M does not beat expectations.